- Research article
- Open Access
Patellofemoral arthroplasty versus total knee arthroplasty for isolated patellofemoral osteoarthritis: a systematic review and meta-analysis
Journal of Orthopaedic Surgery and Research volume 16, Article number: 264 (2021)
Isolated patellofemoral osteoarthritis (PF-OA) is a common subtype of knee osteoarthritis, leading to a huge economic burden on health care systems. Although previous studies have shown that patellofemoral arthroplasty (PFA) and total knee arthroplasty (TKA) have good clinical effects, it remains largely unclear which treatment is more effective for patients with isolated PF-OA. We aimed to compare postoperative function, complications, revision rates, level of physical activity, and satisfaction rate between the two surgical techniques.
Our study followed the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. Search of literature was conducted in MEDLINE, EMBASE, Cochrane Library, and Web of Science until November 2020. The included studies were those that provided direct comparison of postoperative outcomes between PFA and TKA. Data were extracted from eligible studies and combined to calculate the pooled odds ratio (OR) and 95% confidence interval (CI). Sensitivity analysis and subgroup analysis were conducted to evaluate heterogeneity between the two groups.
A total of 7 eligible studies (3 recent randomized controlled trials and 4 nonrandomized controlled trials) were included in this meta-analysis. The pooled results showed that both the PFA group and the TKA group had improved postoperative indicators, suggesting that the two operation modes could improve the knee function and quality of life of patients. Throughout the first 2 years postoperatively, higher activity level, and better functional recovery were observed for PFA compared with TKA in this study; moreover, the differences between the two operation modes were statistically significant (p < 0.05). We found no significant difference in complications, revision rates, and satisfaction rate between the two procedures.
Although there was no observed difference in the complications, revision rates, and satisfaction rate between PFA and TKA, PFA was superior to TKA in terms of knee function and physical activity in the first 2 years postoperatively. Therefore, PFA is a safe, effective, and less invasive treatment for patients with isolated PF-OA. Our findings are consistent with the systematic review of current evidence that PFA may be more suitable for younger patients with high activity needs. Patient selection is, therefore, thought to be of paramount importance. Individualized surgical plan should be designed according to the patient’s age, BMI, KOA site, and activity level and combined with the doctor’s personal experience.
Osteoarthritis (OA) of the knee is a common form of degenerative joint disease, which affects individuals all over the world. Over 100,000 primary knee arthroplasties are conducted annually in the United Kingdom (UK) and were predicted to increase 6-fold by 2030 (UK National Joint Registry 2014) . One-third of OA patients are affected in only one compartment . Studies have shown that the isolated patellofemoral osteoarthritis (PF-OA) affects 11% to 24% of the general population with knee pain who are 55 years and older, with a female preponderance [3, 4]. PF-OA has a substantial negative socioeconomic impact on the health care system due to a high prevalence and the chronic relapsing nature of symptoms.
In the early stage of isolated PF-OA, the treatment options include conservative therapies and minor surgical procedures, such as arthroscopy, cartilage stimulation with microfractures, lateral retinacular release, tibial tuberosity transposition, and cartilage replacement procedures [5,6,7,8,9,10,11]. In the late stages, when severe pain is present, joint arthroplasty such as patellofemoral arthroplasty (PFA) and total knee arthroplasty (TKA) may be recommended [12,13,14]. TKA is perceived to be the gold standard treatment of symptomatic late-stage knee osteoarthritis (KOA) and provides good long-term outcomes . However, for the isolated PF-OA, TKA is not the preferred treatment strategy, especially for younger and highly active patients. PFA is an alternative to TKA for the treatment of isolated PF-OA [16, 17], preserving both tibiofemoral joints and ligamentous structures as a less invasive operation, and enabling a faster recovery . A previous review suggested PFA and TKA have similar results in terms of complications and reoperation rates for isolated PF-OA . However, a recent randomized controlled trial (RCT) comparing TKA with the Avon PFA in patients with isolated patellofemoral disease found a greater overall knee-specific quality of life and improved range of movement 2 years postoperatively for the Avon group . PFA and TKA are two kinds of prostheses with different designs and require different surgical techniques. Choosing the appropriate prosthesis type for isolated PF-OA surgery remains somewhat controversial for patients with isolated PF-OA. Therefore, we conducted a systematic review and meta-analysis to compare PFA and TKA for patients with isolated PF-OA.
The aim of our study was to quantitatively evaluate if the outcomes of PFA and TKA differs with regard to (1) postoperative complications, (2) rates of revision, (3) function, (4) postoperative physical activity, and (5) satisfaction rate.
We strictly conducted this study in accordance with the PRISMA statement (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) . First, the research protocol for this review was determined by all coauthors and then the literature searches begin. With the assistance of an experienced librarian, two authors (Guanrong Peng and Min Liu) developed the search strategy following the PICOS methodology. By November 13, 2020, according to the comprehensive retrieval strategy, we have systematically searched the four major electronic databases, including MEDLINE (through PubMed), EMBASE (through OvidSP), SCI (through Web of Science), and CENTRAL (Cochrane Central Register of Controlled Trials, through the Cochrane Library). To maximize sensitivity, we had no restrictions on the language and publication date of the articles in the whole retrieval process. The literature search strategy for the four databases followed Medical Subject Headings combination with terms. Additionally, the reference lists of each comparative study and reviews were also examined to identify additional relevant studies. The detailed search strategy of this study is shown in Additional file 1.
Inclusion and exclusion criteria
Two authors (Guanrong Peng and Min Liu) independently evaluated the search results by scanning the titles or abstracts or full text. Eligible studies were included in the current systematic review. If there was a disagreement between the two authors on qualification issues, a consensus could be reached by consultation with another author (Yirong Zeng).
All RCTs or non-randomized controlled trials (nRCTs) that directly compared PFA with TKA to treat isolated PF-OA were identified and included. The inclusion criteria were (1) in the original comparative studies, all surgical procedures were primary PFA and TKA; (2) there was no difference in baseline data between the two groups, including age, gender, body mass index (BMI), previous procedures and preoperative outcome measures; (3) complete data were available to calculate the pooled odds ratios (OR) with 95% confidence interval (CI); and (4) at least one of the following outcome indicators was reported: function (e.g., knee function score or range of motion), daily physical activity score, complications (e.g., pain, postoperative joint stiffness, infection, thrombosis, periprosthetic fractures), revision rate of prostheses, and postoperative satisfaction. Exclusion criteria were as follows: (1) literature without available data due to incomplete or unclear information; (2) revision surgery was included; (3) included other surgical procedures; (4) repetitive articles, unable to obtain full text, conference and case reports, reviews, systematic reviews and expert opinions; (5) animal experiments; (6) authors could not distinguish languages; (7) non-conformity with inclusion criteria; and (8) without clear outcome measures and evaluation standard of curative effect.
Study quality assessment
To determine whether biases might have affected the results, the Cochrane Risk Bias Tool (CRBT) was used to assess the risk of bias in RCTs . We assessed the risk of bias in the nonrandomized studies using the Risk of Bias in Non-Randomized Studies of Interventions (ROBINS-I) assessment tool . The ROBINS-I tool evaluates bias including the following aspects: bias due to confounding, bias in the selection of participants, bias in measurement of interventions, bias due to departures from intended interventions, bias due to missing key data, bias in measurement of outcomes, and bias in selection of the reported result. Each study included was independently assessed by two authors (Guanrong Peng and Min Liu). In the case of any controversy, a final consensus was reached through discussion or resolved by a third author (Yirong Zeng).
The first author extracted data from all included studies based on a standardized date collection form, and then two other authors repeated this process to extract data. This standardized data extraction format included the following aspects: (1) study general information (i.e., author, country, journal, year of publication and type of study); (2) population information of study (i.e., sex, age, BMI, and diagnosis); (3) surgery type and follow-up time; and (4) outcome measures (i.e., functional outcomes of knee, daily physical activity score, complications, revision rates, health-related quality of life (HRQOL), and satisfaction rate). Complications were defined as postoperative unfriendly issues. Except the study by Ivan Kamikovski et al. , we contacted the author by phone, email, or other means for more information when the key data of the studies were missed.
We used the OR and associated 95% CI for statistical analysis of each study containing dichotomous variables, such as complications, revision incidence, and satisfaction rate. For continuous variables, including daily physical activity score and knee function score, the mean difference (MD) or standard mean difference (SMD) was used. For continuous data with mean and range values as the outcomes, we used statistical algorithms to calculate standard deviations . Our system analysis only counted those studies that gave both means and standard deviations. The heterogeneity between studies was evaluated by I2 and P value. While the statistical result was P > 0.1 or I2 < 50% (no heterogeneity among the studies), the fixed effect model was applied to merge the effect quantities. Otherwise, the random effect model was used.
After selecting the test mode, sensitivity analysis was conducted when necessary to evaluate the stability of the results. We obtained more specific conclusions through subgroup analysis if data were available. Moreover, forest plots were used to explain the results of individual studies and estimated the effect of each merger separately. Funnel plots were used to detect publication bias for any results. In this system analysis, Review Manager (version 5.3.5 for Windows, the Cochrane Collaboration, the Nordic Cochrane Centre, Copenhagen, 2014) was used for all statistical analyses.
We extracted a total of 1189 potentially relevant citations from the four electronic databases (MEDLINE = 314, EMBASE = 237, SCI = 600, CENTRAL = 38). First, 410 repetitive studies were eliminated by citation management software. Second, 624 irrelevant citations were excluded by browsing the titles and abstracts. Third, 148 of which were excluded again for reasons, such as commentary (or reviews, n = 80), no control groups (n = 41), containing other orthopedic surgery (n = 10), case report (n = 8), lacking raw data (n = 3), no useful outcome date (n = 3), analysis of reasons for revision (n = 2), and surgery technique (n = 1). Finally, a total of 7 articles [15, 20, 25,26,27,28,29] were included in this research. The detailed screening process of this study was shown in Fig. 1.
Study characteristics and quality
In these 7 studies that included 505 patients (509 knees) with isolated PF-OA, there were 246 cases (250 knees) in the PFA group and 259 patients (259 knees) in the TKA group. Two of the seven studies were from Denmark [15, 20], two from the UK [25, 27], one from Canada , one from Germany , and one from the USA . Two studies were published in 2020 [15, 27], two in 2019 [25, 28], two in 2018 [20, 29], and one in 2010 . The follow-up period of the seven studies was differ ranging from 1 year  to 15  years. The mean age ranged from 50 years  to 72 years . Study characteristics, information of related research journals, interventions, patient demographic details, and clinical results for the 7 studies in this meta-analysis were shown in Tables 1 and 2.
We included 3 RCTs [15, 20, 27] and 4 nRCTs [25, 26, 28, 29]. Subgroup analysis was used in the 3 RCTs. RCTs were assessed using the CRBT according to 6 domains of potential biases, while nRCTs were evaluated using ROBINS-I according to 7 domains of potential biases. The specific test qualities of all studies were shown in Additional files 2 and 3.
Complications were defined as postoperative unfriendly issues. Except the study by Ivan Kamikovski et al. , a total of 463 patients were evaluated in 6 studies [15, 20, 25,26,27, 29] to estimate the incidence of complications. Main complications included pain, joint stiffness, activity limitation, infection, unequal length of lower limbs, deep vein thrombosis, revision, operation area paralysis, and periprosthetic fracture. We divided the studies into the RCT and nRCT groups for subgroup analysis. Six articles were tested for heterogeneity, which showed that the heterogeneity of the selected studies was not statistically significant(P = 0.69> 0.1, I2 = 0% < 50%; Fig. 2). The pooled data showed no statistical significance in the incidence of complications between the two groups in the fixed effect model (OR 0.66, 95% CI 0.41–1.07, Z = 1.68, P = 0.09; Fig. 2). The funnel symmetry demonstrated that there was no significant publication bias regarding the incidence of complications between the two group (Fig. 3). In other words, there was no significant difference in the incidence of complications between the two groups.
Six studies assessed the incidence of revisions in a total of 463 patients [15, 20, 25,26,27, 29]. Revision surgery was reported in both groups. However, subgroup analysis indicated that the revision rates between the PFA and TKA groups were not statistically different (OR 2.23, 95% CI 0.70–7.06, Z = 1.36, P = 0.17; Fig. 4). That was to say, the revision rate of PFA was not higher than that of TKA.
The results of knee function were compared by the patient-reported outcome measures. Fredborg et al.  did not give a knee function score. Therefore, six [20, 25,26,27,28,29] out of the seven studies assessed knee function using different knee function scoring systems. Ivan Kamikovski et al.  used Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) functional score (0 best, 68 worst). Dahm et al.  used the American Knee Society scoring system (AKSS, 0 worst, 100 best). The remaining four studies used the Oxford Knee Score system (OKS, 0 worst, 48 best) [20, 25, 27, 29]. Five out of six studies reported better functional scores in the PFA group [20, 25 - 27, 29]. Furthermore, among four studies that used the OKS [20, 25, 27, 29], the pooled data showed that there was a statistical difference between PFA and TKA (MD − 3.78; 95% CI, − 7.18, − 0.38; Z = 2.18, P = 0.03 < 0.05; Fig. 5).
Daily physical activity scores
Three studies reported using the University of California Los Angeles Physical Activity Rating Scale (UCLA, 0 worst, 10 best) to assess physical activity [26,27,28]. There was significant heterogeneity among these three studies(P = 0.002< 0.1, I2 = 84% > 50%). The study of Ivan Kamikovski et al.  was excluded in sensitivity analysis. While the UCLA activity scores of the two groups were improved in the final follow-up, the recovery of physical activity was better in the PFA group (MD 0.93, 95% CI 0.25–1.62, Z = 2.68, P = 0.007; Fig. 6).
A total of 213 patients were finally followed up for the rate of satisfaction in three studies [25,26,27]. Compared with TKA, PFA had higher functional results and physical activity scores. However, the pooled data showed no significant difference in satisfaction rates between PFA and TKA (OR 0.95, 95% CI 0.44–2.05, Z = 0.14, P = 0.89; Fig. 7).
In recent years, studies have shown that both PFA and TKA have achieved satisfactory results in the treatment of patients with PF-OA [30,31,32,33,34,35]. However, surgical treatment options for severe symptomatic isolated PF-OA remain controversial. We objectively and quantitatively designed this meta-analysis to compare the effectiveness of PFA and TKA for isolated PF-OA. Perrone et al.  noted that patient-reported outcome measures (PROMs) are extensively used as an important outcomes measure to evaluate patients undergoing joint replacement surgery. Studies included in our meta-analysis also performed PROMs as evaluation methods of outcome. All the outcome measures were improved in both PFA and TKA groups, suggesting that the two operation modes could improve the function and quality of life. Throughout the first 2 years after operation, a higher physical activity level and better functional recovery were observed for PFA compared with TKA, which was consistent with the conclusion of previous studies [15, 20, 28]. The pooled data showed no statistical difference between the two groups in terms of complications, revision rates, and satisfaction rate.
The premise for any surgical operation to obtain satisfactory clinical efficacy and high safety is to strictly grasp its indications and contraindications. Therefore, selecting the suitable patients for PFA is a challenge for the surgeons. PFA has been defined by 6 classic indications and 11 consensus contraindications [36,37,38]. Indications include (1) isolated degenerative osteoarthritis of patellofemoral joint, (2) severe patellofemoral joint degeneration with ineffective long-term conservative treatment (at least 3–6 months) and/or failure of conservative surgery, (3) posttraumatic patellofemoral arthritis, (4) generalized grade III patellofemoral arthritis chondropathy, (5) failure of a previous extensor unloading surgical procedure, and (6) degenerative changes with or without instability due to patellofemoral dysplasia. The contraindications include (1) no conservative treatment or other sources of pain cannot be excluded, (2) arthritis of greater than Kellgren-Lawrence Grade 1 involving the tibiofemoral articulation, (3) osteoarthritis or chondrosis of the patellofemoral joint of Grade 3 or less, (4) uncorrected patellofemoral instability or malalignment, (5) patella baja, (6) systemic inflammatory arthritis, (7) active infection, (8) uncorrected tibiofemoral mechanical malalignment (varus> 5° or valgus> 8°), (9) psychogenic pain, (10) evidence of chronic regional pain syndrome, and (11) fixed loss of knee range of motion (− 10° of extension to 110° of flexion at a minimum).
PFA is a relatively early clinical technology, so far a large number of scholars have carried out research and reported their results. Leadbetter WB et al.  reported that factors including gender, age(< 40 years), obesity (BMI of > 30 kg/m2), primary osteoarthritis, patella alta, and a high activity level might compromise the clinical outcomes of PFA. Van Jonbergen et al.  considered that obesity (BMI > 30) was not only a risk factor for patellofemoral arthritis, but also a risk factor for revision after PFA. Nevertheless, Jared et al.  proffered that 35 obese (BMI > 30) patients with isolated PF-OA could achieve the same improvement in function as non-obese (BMI: 18.5–25) patients following PFA, and there was no difference in PFA revision rate between the two. As is known to all, the mold of implant is one of the most important considerations affecting the clinical results. Modern PFA implants have been widely used due to their higher functional success rates and lower complication rate. Moreover, as technology advances, including custom implants and robotic assistive programs, the advantages of PFA may be further enhanced [41, 42]. Additionally, studies have already shown that 66% to 100% of patients with PFA achieved good to excellent results over a 3- to 17-year follow-up [43,44,45,46,47]. For example, Cartier et al.  reported on a study of the first-generation of PFA that 55 of 65 patients achieved good to excellent results at 4 years. Van der List JP et al.  found that the 5-, 10-, 15- and 20-year survival rate of PFA prosthesis was 91.7%, 83.3%, 74.9%, and 66.6%, respectively. In addition, in a study of 62 patients with a mean follow-up of 5.0 ± 2.1 years, Jonas Pogorzelski et al.  demonstrated that 94% of the patients with PFA were able to return to the same or higher level of exercise, while 74% of the patients showed improved ability to perform sports.
Admittedly, the “gold standard” for the primary treatment of symptomatic advanced KOA is TKA. Meanwhile, TKA is considered as a benchmark for the treatment of isolated PF-OA . Nevertheless, the resection of cruciate ligament in TKA affects the participation and range of motion in high demand activities [48, 49]. Besides, the revision rate increased by two to three times among young patients who received TKA in the following decades . In recent years, many scholars have shown renewed interest in the field of PFA. With the improvement of PFA prosthesis design and surgical techniques, modern PFA has become a reasonable choice for young isolated PF-OA patients to delay TKA . It has shown a three to four times improved survivorship than the first generation implants . There were 3 RCTs [15, 20, 27] and 4 nRCTs [25, 26, 28, 29] comparing PFA and TKA for patients with isolated PF-OA found no difference between the interventions in terms of satisfaction rates, complications, and revision rates. Shubin Stein et al.  noted that the majority of PFA patients could return to preoperative level of physical activity, which was also found in our study. Leadbetter et al.  discovered that PFA patients could return to tennis, ballet, skiing and other activities in the short term.
Compared with TKA, the advantages of PFA include lower intraoperative blood loss, shorter surgical duration and tourniquet time, the minimal femoral bone loss as well as the preservation of the tibiofemoral articulation, menisci, and ligaments [41, 42]. The minimally invasive PFA technology allows a faster rehabilitation and better range of motion and function for young patients in a short time after operation. Notably, for younger patients with isolated PF-OA, TKA is defined as a more invasive procedure because it requires the replacement of two healthy tibiofemoral joints [31, 37]. Compared with the older population, TKA has a higher revision rate among younger patients . What is more, PFA is at least 1.0% more effective than TKA in the terms of cost-effectiveness . PFA may bring good clinical effects and economic benefits to patients when it is accepted as a practical technique for the treatment of isolated PF-OA. Additionally, if tibiofemoral arthritis progression or implant failure occurs, PFA can be used as a bridge operation for TKA in the future potentially reducing the revision rates. Of note, based on a proper patient selection, precise prosthesis design and accurate surgical technique, Shubin Stein et al.  believed that PFA should be more and more popular in the young active patients with isolated PF-OA. However, previous studies have been reported that the progression of tibiofemoral arthritis is considered to be a common cause of failure of modern PFA prostheses [31, 44]. Furthermore, Dahm et al. suggested that patients with idiopathic PF-OA may be more likely to develop generalized tibiofemoral arthritis . Odgaard et al.  reported that there were two revisions within 2 years in patients with PFA. Selecting the right patient for PFA, therefore, thought to be of paramount importance.
To the best of our knowledge, this appears to be the first meta-analysis to compare PFA and TKA for patients with isolated PF-OA in terms of postoperative function, complications, revision rate, physical activity and satisfaction. Furthermore, the great strength of this study is that it's the latest meta-analysis to objectively and quantitatively compare the efficacy between the two surgical techniques. Compared with a previous systematic review and meta-analysis , we included a number of new clinical studies [15, 20, 25, 27,28,29] up to 2020. We noted that an excellent meta-analysis has been published previously by Dy et al. , but the purpose was mainly to compare the postoperative complications of PFA and TKA. Consequently, our results are more up-to-date. Furthermore, we conducted the current study in accordance with the PRISMA statement and critically evaluated the quality of all selected studies.
However, our meta-analysis has some limitations, which should be considered when interpreting the results. First, some studies have been inevitably omitted or not identified due to search strategy, although we consulted a professional librarian and optimizing the retrieval strategy. Second, only 3 of 7 studies were RCTs in our research, in which it is very hard to blind participants and investigators. Because surgical procedures are determined by the patient and the physician, it is difficult to maintain a baseline balance between the PFA and TKA groups. Third, the results of our systematic analysis may be influenced by different prosthesis types, surgical technique and postoperative care. Fourth, the follow-up period of 7 studies included in this meta-analysis is heterogenous ranging from 1 to 15 years, which may have introduced recall bias and varying time points for collection of postoperative patient-reported outcome measures. Finally, this meta-analysis included studies that chose results cutoff of two years after surgery, the postoperative outcomes may also be associated with the follow-up time. Therefore, longer follow-up is necessary to compare the medium and long-term efficacy of the two surgical methods.
In this up-to-date meta-analysis, while satisfactory clinical effectiveness was achieved by both PFA and TKA, PFA showed superior functional results and UCLA scores compared with TKA. There were no significant differences in complications, revision rates and satisfaction rate between PFA and TKA for isolated PF-OA. Thus, younger active patients may be good candidates for PFA. High-quality, multicenter, large sample prospective randomized controlled trials are needed to confirm these findings. In general, our study may provide more reliable objective evidence for clinical treatment of isolated PF-OA.
Availability of data and materials
The datasets used and/or analyzed during this study are not publicly available due to feasibility, but are available from the corresponding authors on reasonable request.
Total knee arthroplasty
Randomized controlled trial
Nonrandomized controlled trials
Body mass index
University of California Los Angeles
Mohammad HR, Strickland L, Hamilton TW, Murray DW. Long-term outcomes of over 8,000 medial Oxford Phase 3 Unicompartmental Knees-a systematic review. Acta Orthop. 2018;89(1):101–7.
Ledingham J, Regan M, Jones A, Doherty M. Radiographic patterns and associations of osteoarthritis of the knee in patients referred to hospital. Ann Rheum Dis. 1993;52(7):520–6.
Davies AP, Vince AS, Shepstone L, Donell ST, Glasgow MM. The radiologic prevalence of patellofemoral osteoarthritis. Clin Orthop Relat Res. 2002;402:206–12.
McAlindon TE, Snow S, Cooper C, Dieppe PA. Radiographic patterns of osteoarthritis of the knee joint in the community: the importance of the patellofemoral joint. Ann Rheum Dis. 1992;51(7):844–9.
Crossley KM, Vicenzino B, Pandy MG, Schache AG, Hinman RS. Targeted physiotherapy for patellofemoral joint osteoarthritis: a protocol for a randomised, single-blind controlled trial. BMC Musculoskelet Disord. 2008;9:122.
Federico DJ, Reider B. Results of isolated patellar debridement for patellofemoral pain in patients with normal patellar alignment. Am J Sports Med. 1997;25(5):663–9.
Fulkerson JP. Alternatives to patellofemoral arthroplasty. Clin Orthop Relat Res. 2005;436:76–80.
Gallo RA, Feeley BT. Cartilage defects of the femoral trochlea. Knee Surg Sports Traumatol Arthrosc. 2009;17(11):1316–25.
Mihalko WM, Boachie-Adjei Y, Spang JT, Fulkerson JP, Arendt EA, Saleh KJ. Controversies and techniques in the surgical management of patellofemoral arthritis. Instr Course Lect. 2008;57:365–80.
van Jonbergen HP, Poolman RW, van Kampen A. Isolated patellofemoral osteoarthritis. Acta Orthop. 2010;81(2):199–205.
Yanke AB, Wuerz T, Saltzman BM, Butty D, Cole BJ. Management of patellofemoral chondral injuries. Clin Sports Med. 2014;33(3):477–500.
Grelsamer RP, Stein DA. Patellofemoral arthritis. J Bone Joint Surg Am. 2006;88(8):1849–60.
Kobayashi S, Pappas E, Fransen M, Refshauge K, Simic M. The prevalence of patellofemoral osteoarthritis: a systematic review and meta-analysis. Osteoarthritis Cartilage. 2016;24(10):1697–707.
Lankhorst NE, Damen J, Oei EH, Verhaar JAN, Kloppenburg M, Bierma-Zeinstra SMA, et al. Incidence, prevalence, natural course and prognosis of patellofemoral osteoarthritis: the Cohort Hip and Cohort Knee study. Osteoarthritis Cartilage. 2017;25(5):647–53.
Fredborg C, Odgaard A, Sørensen J. Patellofemoral arthroplasty is cheaper and more effective in the short term than total knee arthroplasty for isolated patellofemoral osteoarthritis: cost-effectiveness analysis based on a randomized trial. Bone Joint J. 2020;102-b(4):449–57.
Metcalfe AJ, Ahearn N, Hassaballa MA, Parsons N, Ackroyd CE, Murray JR, et al. The Avon patellofemoral joint arthroplasty: two- to 18-year results of a large single-centre cohort. Bone Joint J. 2018;100-b(9):1162–7.
Strickland SM, Bird ML, Christ AB. Advances in Patellofemoral Arthroplasty. Curr Rev Musculoskelet Med. 2018;11(2):221–30.
Clark AL. Osteoarthritis. what we have been missing in the patellofemoral joint. Exerc Sport Sci Rev. 2008;36(1):30–7.
Sebastiano Vasta RP, Zampogna B, Espregueira-Mendes J, Amendola A. Current design (onlay) PFA implants have similar__complication and reoperation rates compared to__those of TKA for isolated PF osteoarthritis___a systematic review with quantitative analysis. JISAKOS. 2016;1(5):257–68.
Odgaard A, Madsen F, Kristensen PW, Kappel A, Fabrin J. The Mark Coventry Award: Patellofemoral Arthroplasty Results in Better Range of Movement and Early Patient-reported Outcomes Than TKA. Clin Orthop Relat Res. 2018;476(1):87–100.
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8(5):336–41.
Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. Bmj. 2011;343:d5928.
Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. ROBINS-I. a tool for assessing risk of bias in non-randomised studies of interventions. Bmj. 2016;355:i4919.
Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5:13.
Clement ND, Howard TA, Immelman RJ, MacDonald D, Patton JT, Lawson GM, et al. Patellofemoral arthroplasty versus total knee arthroplasty for patients with patellofemoral osteoarthritis: equal function and satisfaction but higher revision rate for partial arthroplasty at a minimum eight years’ follow-up. Bone Joint J. 2019;101-b(1):41–6.
Dahm DL, Al-Rayashi W, Dajani K, Shah JP, Levy BA, Stuart MJ. Patellofemoral arthroplasty versus total knee arthroplasty in patients with isolated patellofemoral osteoarthritis. Am J Orthop (Belle Mead NJ). 2010;39(10):487–91.
Joseph MN, Achten J, Parsons NR, Costa ML. The PAT randomized clinical trial. Bone Joint J. 2020;102-b(3):310–8.
Kamikovski I, Dobransky J, Dervin GF. The Clinical Outcome of Patellofemoral Arthroplasty vs Total Knee Arthroplasty in Patients Younger Than 55 Years. J Arthroplasty. 2019;34(12):2914–7.
Perrone FL, Baron S, Suero EM, Lausmann C, Kendoff D, Zahar A, et al. Patient-reported outcome measures (PROMs) in patients undergoing patellofemoral arthroplasty and total knee replacement: A comparative study. Technol Health Care. 2018;26(3):507–14.
Laskin RS, van Steijn M. Total knee replacement for patients with patellofemoral arthritis. Clin Orthop Relat Res. 1999;367:89–95.
Lonner JH. Patellofemoral arthroplasty. pros, cons, and design considerations. Clin Orthop Relat Res. 2004;428:158–65.
Meding JB, Wing JT, Keating EM, Ritter MA. Total knee arthroplasty for isolated patellofemoral arthritis in younger patients. Clin Orthop Relat Res. 2007;464:78–82.
Merchant AC. Early results with a total patellofemoral joint replacement arthroplasty prosthesis. J Arthroplasty. 2004;19(7):829–36.
Mont MA, Haas S, Mullick T, Hungerford DS. Total knee arthroplasty for patellofemoral arthritis. J Bone Joint Surg Am. 2002;84(11):1977–81.
Parvizi J, Stuart MJ, Pagnano MW, Hanssen AD. Total knee arthroplasty in patients with isolated patellofemoral arthritis. Clin Orthop Relat Res. 2001;392:147–52.
Gupta RR, Zywiel MG, Leadbetter WB, Bonutti P, Mont MA. Scientific evidence for the use of modern patellofemoral arthroplasty. Expert Rev Med Devices. 2010;7(1):51–66.
Leadbetter WB, Ragland PS, Mont MA. The appropriate use of patellofemoral arthroplasty: an analysis of reported indications, contraindications, and failures. Clin Orthop Relat Res. 2005;436:91–9.
Leadbetter WB, Seyler TM, Ragland PS, Mont MA. Indications, contraindications, and pitfalls of patellofemoral arthroplasty. J Bone Joint Surg Am. 2006;88(Suppl 4):122–37.
van Jonbergen HP, Werkman DM, Barnaart LF, van Kampen A. Long-term outcomes of patellofemoral arthroplasty. J Arthroplasty. 2010;25(7):1066–71.
Tishelman JC, Pyne A, Kahlenberg CA, Gruskay JA, Strickland SM. Obesity Does Not Affect Patient-Reported Outcomes following Patellofemoral Arthroplasty. J Knee Surg. 2020.
Hernigou P, Caton J. Design, operative technique and ten-year results of the Hermes™ patellofemoral arthroplasty. Int Orthop. 2014;38(2):437–42.
Konan S, Haddad FS. Midterm Outcome of Avon Patellofemoral Arthroplasty for Posttraumatic Unicompartmental Osteoarthritis. J Arthroplasty. 2016;31(12):2657–9.
Akhbari P, Malak T, Dawson-Bowling S, East D, Miles K, Butler-Manuel PA. The Avon Patellofemoral Joint Replacement: Mid-Term Prospective Results from an Independent Centre. Clin Orthop Surg. 2015;7(2):171–6.
Cartier P, Sanouiller JL, Grelsamer R. Patellofemoral arthroplasty. 2-12-year follow-up study. J Arthroplasty. 1990;5(1):49–55.
Godshaw B, Kolodychuk N, Williams GK Jr, Browning B, Jones D. Patellofemoral Arthroplasty. Ochsner J. 2018;18(3):280–7.
Pogorzelski J, Rupp MC, Ketzer C, Cotic M, Lutz P, Beeck S, et al. Reliable improvements in participation in low-impact sports following implantation of a patellofemoral inlay arthroplasty at mid-term follow-up. Knee Surg Sports Traumatol Arthrosc. 2020.
van der List JP, Chawla H, Zuiderbaan HA, Pearle AD. Survivorship and functional outcomes of patellofemoral arthroplasty: a systematic review. Knee Surg Sports Traumatol Arthrosc. 2017;25(8):2622–31.
Bull AM, Kessler O, Alam M, Amis AA. Changes in knee kinematics reflect the articular geometry after arthroplasty. Clin Orthop Relat Res. 2008;466(10):2491–9.
Noble PC, Gordon MJ, Weiss JM, Reddix RN, Conditt MA, Mathis KB. Does total knee replacement restore normal knee function? Clin Orthop Relat Res. 2005;431:157–65.
Chawla H, Nwachukwu BU, van der List JP, Eggman AA, Pearle AD, Ghomrawi HM. Cost effectiveness of patellofemoral versus total knee arthroplasty in younger patients. Bone Joint J. 2017;99-b(8):1028–36.
Dy CJ, Franco N, Ma Y, Mazumdar M, McCarthy MM, Gonzalez Della Valle A. Complications after patello-femoral versus total knee replacement in the treatment of isolated patello-femoral osteoarthritis. A meta-analysis. Knee Surg Sports Traumatol Arthrosc. 2012;20(11):2174–90.
Shubin Stein BE, Brady JM, Grawe B, Tuakli-Wosornu Y, Nguyen JT, Wolfe E, et al. Return to Activities After Patellofemoral Arthroplasty. Am J Orthop (Belle Mead NJ). 2017;46(6):E353–e357.
Leadbetter WB, Kolisek FR, Levitt RL, Brooker AF, Zietz P, Marker DR, et al. Patellofemoral arthroplasty: a multi-centre study with minimum 2-year follow-up. Int Orthop. 2009;33(6):1597–601.
Dy CJ, Marx RG, Bozic KJ, Pan TJ, Padgett DE, Lyman S. Risk factors for revision within 10 years of total knee arthroplasty. Clin Orthop Relat Res. 2014;472(4):1198–207.
One of the first authors (Guanrong Peng) would like to thank his wife Yujie Zeng for her help in grammar expression. In addition, we would like to thank Professor Yirong Zeng and his team for their expertise and commitment.
This work was supported by High-Level University Construction Project of Guangzhou University of Chinese Medicine (A1AFD018171Z11068) in the form of covering the consultation fees of data statistical analysis. Yirong Zeng received scientific funding from High-Level University Construction Project of Guangzhou University of Chinese Medicine and the grant number A1-AFD018171Z11068.
Ethics approval and consent to participate
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Peng, G., Liu, M., Guan, Z. et al. Patellofemoral arthroplasty versus total knee arthroplasty for isolated patellofemoral osteoarthritis: a systematic review and meta-analysis. J Orthop Surg Res 16, 264 (2021). https://doi.org/10.1186/s13018-021-02414-5
- Patellofemoral osteoarthritis
- Patellofemoral arthroplasty
- Total knee arthroplasty
- Patient-reported outcome measure
- Systematic review